BridgeMD
New treatment option for Cholecystitis
Official title EOIB for Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT06656299
What this study is testing
What is Bupivacaine injection?
Bupivacaine injection is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for cholecystitis.
Also referred to as Local anesthetic injection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Laparoscopic cholecystectomy, while less painful compared to conventional methods, is still a surgery that can cause significant pain for patients. Preventing postoperative pain is crucial for reducing respiratory complications, shortening hospital stays, and increasing patient satisfaction.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients aged 18 to 65 who will be scheduled for an elective laparoscopic cholecystectomy under general anesthesia
- ASA (American Society of Anesthesiologists) I-II-III
You likely can't join if
- presence of coagulation disorder
- infection at the injection site of the block
- known allergy to local anesthetics
- advanced hepatic, heart or renal failure
- history of abdominal surgery or trauma
- conversion of laparoscopic to open surgery
See the full eligibility criteria
- Patients aged 18 to 65 who will be scheduled for an elective laparoscopic cholecystectomy under general anesthesia
- ASA (American Society of Anesthesiologists) I-II-III
- presence of coagulation disorder
- infection at the injection site of the block
- known allergy to local anesthetics
- advanced hepatic, heart or renal failure
- history of abdominal surgery or trauma
- conversion of laparoscopic to open surgery
- consumption of any pain killers within the 24 h before the operation
- chronic opioid consumption
- pregnancy
- alcohol or drug abuse
- body mass index (BMI) ≥ 35 kg m-2
- Impairment of the patient's cognitive functions (such as Alzheimer's disease, dementia, etc.).
- Cholecystectomy cases performed under emergency conditions.
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.